A new study reports that an oral GLP-1–based pill produces substantial weight loss over 36 weeks. According to The Hill, participants treated with the oral GLP-1 pill lose nearly 12% of their body weight during the study period. The article describes how the medication works by stimulating insulin secretion, reducing appetite, and improving perceived satisfaction, all of which contribute to weight reduction. The findings are presented as evidence of the drug’s effectiveness in promoting weight loss within the trial timeframe. Based on the available reporting, the primary outcomes emphasized are the magnitude of weight loss over 36 weeks and the proposed biological mechanisms related to glucose regulation and appetite control. Details such as the study size, dosing regimen, and comparison to placebo or other treatments are not provided in the supplied excerpts, and therefore cannot be independently confirmed here. Overall, the reporting aligns on the headline result: the oral GLP-1 pill produces close to a 12% average weight loss at 36 weeks.